Cook, A M <br/><br/>
Comparison of mitozantrone and epirubicin in advanced breast cancer.  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  1996 
 - 363-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0936-6555 
<br/><br/><label>Standard No.: </label>10.1016/s0936-6555(96)80079-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Epirubicin--adverse effects<br/>Heart Diseases--chemically induced<br/>Humans<br/>Middle Aged<br/>Mitoxantrone--adverse effects<br/>Neoplasm Metastasis<br/>Survival Analysis<br/>Treatment Outcome